These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
422 related articles for article (PubMed ID: 2471812)
1. Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents. Parry NR; Barnett PV; Ouldridge EJ; Rowlands DJ; Brown F J Gen Virol; 1989 Jun; 70 ( Pt 6)():1493-503. PubMed ID: 2471812 [TBL] [Abstract][Full Text] [Related]
2. Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies. Bolwell C; Clarke BE; Parry NR; Ouldridge EJ; Brown F; Rowlands DJ J Gen Virol; 1989 Jan; 70 ( Pt 1)():59-68. PubMed ID: 2471783 [TBL] [Abstract][Full Text] [Related]
3. Neutralizing epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites. Barnett PV; Ouldridge EJ; Rowlands DJ; Brown F; Parry NR J Gen Virol; 1989 Jun; 70 ( Pt 6)():1483-91. PubMed ID: 2471811 [TBL] [Abstract][Full Text] [Related]
4. Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites. Xie QC; McCahon D; Crowther JR; Belsham GJ; McCullough KC J Gen Virol; 1987 Jun; 68 ( Pt 6)():1637-47. PubMed ID: 2438378 [TBL] [Abstract][Full Text] [Related]
5. Antigenicity and immunogenicity of synthetic peptides of foot-and-mouth disease virus. Meloen RH; Puyk WC; Meijer DJ; Lankhof H; Posthumus WP; Schaaper WM J Gen Virol; 1987 Feb; 68 ( Pt 2)():305-14. PubMed ID: 2434606 [TBL] [Abstract][Full Text] [Related]
6. Analysis of foot-and-mouth disease virus type O1 Brugge neutralization epitopes using monoclonal antibodies. Stave JW; Card JL; Morgan DO J Gen Virol; 1986 Oct; 67 ( Pt 10)():2083-92. PubMed ID: 2428926 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus. Tosh C; Venkataramanan R; Pattnaik B; Hemadri D; Sanyal A Acta Virol; 1999 Aug; 43(4):219-25. PubMed ID: 10749367 [TBL] [Abstract][Full Text] [Related]
8. A high proportion of anti-peptide antibodies recognize foot-and-mouth disease virus particles. Parry NR; Syred A; Rowlands DJ; Brown F Immunology; 1988 Aug; 64(4):567-72. PubMed ID: 2844657 [TBL] [Abstract][Full Text] [Related]
9. The main antigenic determinant detected by neutralizing monoclonal antibodies on the intact foot-and-mouth disease virus particle is absent from isolated VPI. Meloen RH; Briaire J; Woortmeyer RJ; van Zaane D J Gen Virol; 1983 May; 64(Pt 5):1193-8. PubMed ID: 6188800 [TBL] [Abstract][Full Text] [Related]
10. A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. Mateu MG; Martínez MA; Capucci L; Andreu D; Giralt E; Sobrino F; Brocchi E; Domingo E J Gen Virol; 1990 Mar; 71 ( Pt 3)():629-37. PubMed ID: 1690261 [TBL] [Abstract][Full Text] [Related]
11. Host cell selection of antigenic variants of foot-and-mouth disease virus. Bolwell C; Brown AL; Barnett PV; Campbell RO; Clarke BE; Parry NR; Ouldridge EJ; Brown F; Rowlands DJ J Gen Virol; 1989 Jan; 70 ( Pt 1)():45-57. PubMed ID: 2471782 [TBL] [Abstract][Full Text] [Related]
12. [Synthetic peptides simulating the protective epitopes of VP1 protein of foot-and-mouth disease virus type O and A]. Surovoĭ AIu; Vol'pina OM; Ivanov VT; Chepurkin AV; Ivaniushchenkov VN Bioorg Khim; 1987 Aug; 13(8):1132-5. PubMed ID: 2445357 [TBL] [Abstract][Full Text] [Related]
13. Reactivity with monoclonal antibodies of viruses from an episode of foot-and-mouth disease. Mateu MG; Rocha E; Vicente O; Vayreda F; Navalpotro C; Andreu D; Pedroso E; Giralt E; Enjuanes L; Domingo E Virus Res; 1987 Sep; 8(3):261-74. PubMed ID: 2446442 [TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse. Barnett PV; Samuel AR; Pullen L; Ansell D; Butcher RN; Parkhouse RM J Gen Virol; 1998 Jul; 79 ( Pt 7)():1687-97. PubMed ID: 9680132 [TBL] [Abstract][Full Text] [Related]
15. Evidence for at least four antigenic sites on type O foot-and-mouth disease virus involved in neutralization; identification by single and multiple site monoclonal antibody-resistant mutants. McCahon D; Crowther JR; Belsham GJ; Kitson JD; Duchesne M; Have P; Meloen RH; Morgan DO; De Simone F J Gen Virol; 1989 Mar; 70 ( Pt 3)():639-45. PubMed ID: 2471793 [TBL] [Abstract][Full Text] [Related]
17. [Antigenic structure of the foot-and-mouth disease virus. III. Immunogenic properties of synthetic peptides of the sequence of the immunodominant region of VP1 proteins of the O1K and A22 strains of foot-and-mouth virus]. Surovoĭ AIu; Gel'fanov VM; Vol'pina OM; Ivanov VT; Chepurkin AV; Chepurkin AV; Ivaniushchenkov VM; Driagalin NN; Burdov AN Bioorg Khim; 1989 Sep; 15(9):1185-92. PubMed ID: 2480134 [TBL] [Abstract][Full Text] [Related]
18. Selection of antigenic variants of foot-and-mouth disease virus in the absence of antibodies, as revealed by an in situ assay. Diez J; Mateu MG; Domingo E J Gen Virol; 1989 Dec; 70 ( Pt 12)():3281-9. PubMed ID: 2481712 [TBL] [Abstract][Full Text] [Related]
19. Location of neutralizing epitopes defined by monoclonal antibodies generated against the outer capsid polypeptide, VP1, of foot-and-mouth disease virus A12. Robertson BH; Morgan DO; Moore DM Virus Res; 1984 Sep; 1(6):489-500. PubMed ID: 6085200 [TBL] [Abstract][Full Text] [Related]
20. Foot-and-mouth disease and its antigens. Bachrach HL Adv Exp Med Biol; 1985; 185():27-46. PubMed ID: 2416203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]